Final Glance: Biotechnology companies
AP - Wed Aug 13, 5:14PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 1:37PM CDT
Shares of Dendreon Corporation (DNDN) were down significantly after the company warned that it will not be able to repay or refinance its notes due 2016.
Midday Glance: Biotechnology companies
AP - Wed Aug 13, 12:50PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
BioDelivery Sciences Q2 Loss Narrows, Up on Solid Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 12:02PM CDT
Shares of BioDelivery Sciences International, Inc. (BDSI) jumped 7.58 % after the company reported its second-quarter 2014 results.
Pharmacyclics Has Edge Over Blood Cancer Competitors
at The Street - Wed Aug 13, 9:49AM CDT
Imbruvica will be an important part of the treatment landscape for blood cancers.
Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 9:40AM CDT
Intercept Pharmaceuticals, Inc. (ICPT) reported earnings of $1.51 per share in the quarter comparing favorably with the Zacks Consensus estimate of a loss of $1.10.
Early Glance: Biotechnology companies
AP - Wed Aug 13, 9:32AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Gilead Sciences,Melco Crown Entertainment,Banco Santander, BarclaysandDeutsche Bankhighlighted as Zacks Bull and Bear of the Day
PR Newswire - Wed Aug 13, 8:30AM CDT
Zacks Equity Research highlights Gilead Sciences (Nasdaq:GILD-Free Report) as the Bull of the Day and Melco Crown Entertainment (Nasdaq:MPEL-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onBanco Santander, S.A. (NYSE:SAN-Free Report), Barclays PLC (NYSE:BCS-Free Report) and Deutsche Bank AG (NYSE
Celladon (CLDN) Falls: Stock Goes Down 6.2% - Tale of the Tape
Zacks Research Stuff - Zacks Investment Research - Wed Aug 13, 7:30AM CDT
Celladon stock fell over 6% last trading session, continuing its recent downtrend
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Kevin Cook - ZACKS - Wed Aug 13, 2:06AM CDT
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Apple, Facebook Among 5 Top Rated Big Cap Stocks
at Investor's Business Daily - Tue Aug 12, 7:35PM CDT
Stability is a critical determination in picking stock-watch candidates when the market is in correction. Today's Screen Of The Day is Big Cap Leaders, companies with top-notch fundamentals and a market capitalization of at least $15 billion. The...
Regeneron's Eye Drug Eylea Cleared in the EU for DME - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 4:20PM CDT
Regeneron's (REGN) Eylea has been approved for a third indication in the EU.
Tekmira Shares Continue to Rise in the Search for Ebola Cure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 3:20PM CDT
Shares of Tekmira (TKMR) rose for the second successive day following the FDA announcement on TKM-Ebola.
Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 1:49PM CDT
Sarepta reported second quarter loss of 85 cents per share compared to a loss of 60 cents per share in the year-ago quarter.
Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 10:30AM CDT
Spectrum Pharmaceuticals (SPPI) reported second-quarter 2014 earnings of 16 cents per share, compared to the year-ago loss of 15 cents.
MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 10:05AM CDT
MannKind's (MNKD) loss of 19 cents per share was wider than the Zacks Consensus Estimate of a loss of 11 cents
Intercept Pharma Soars On Liver-Disease Drug Data
at Investor's Business Daily - Tue Aug 12, 9:48AM CDT
Biotech Intercept Pharmaceuticals (ICPT) was riding high on an upgrade and multiple price-target increases after it issued new data late Monday on its fatty-liver-disease drug candidate. Intercept Pharma stock vaulted 31% in early trading on the...